Understanding the Crohn’s disease patient [whitepaper]

At Antidote, we understand that successfully engaging patients for a clinical trial starts with a deep understanding of the patient population. Knowing who patients are, what motivates them, and what messages will resonate with them can all be beneficial when connecting with individuals who may be eligible to take part in specific studies.

We recently analyzed a data set of nearly 1,000 Crohn’s patients to determine how best to reach these individuals with clinical trial opportunities. The data we collect as patients search for trials allows us to understand the motivational factors that drive patients to participate in research — and to plan out our recruitment accordingly. 

The data we collected includes patterns of and insights on flare-ups, resections, and medication history. To get the details on these insights and learn more about our work, get the whitepaper today.